Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yong-Yu Liu

Showing results (11-20 of 66) with videos related to

Pageof 7
Sort By:
Bio-Protocol|April 27, 2026
Quantitative Analysis of Splenic Natural Killer Cells of Mice Using Imaging Flow CytometryMohammad N Amin, Md Saqline Mostaq, Mohammad B Uddin, et al.
World Journal of Gastroenterology|December 31, 2014
Effect of bilateral supraclavicular postoperative radiotherapy in middle and lower thoracic esophageal carcinomaYi Ren, Chang Su, Yang Zhou, et al.
International Journal of Molecular Sciences|June 13, 2025
Glucosylceramide Synthase, a Key Enzyme in Sphingolipid Metabolism, Regulates Expression of Genes Accounting for Cancer Drug ResistanceMd Saqline Mostaq, Lin Kang, Gauri A Patwardhan, et al.
Journal of Thoracic Disease|January 16, 2015
Thoracoscopic left upper lobectomy with systematic lymph nodes dissection under left pulmonary artery clampingYi-Nan Dong, Nan Sun, Yi Ren, et al.
Apoptosis : an International Journal on Programmed Cell Death|November 26, 2010
Mutant p53 exhibits trivial effects on mitochondrial functions which can be reactivated by ellipticine in lymphoma cellsFei Wang, Jianfeng Liu, Delira Robbins, et al.
Cancer Research|February 1, 2011
Suppression of glucosylceramide synthase restores p53-dependent apoptosis in mutant p53 cancer cellsYong-Yu Liu, Gauri A Patwardhan, Kaustubh Bhinge, et al.
Chemical Biology & Drug Design|October 28, 2014
Novel Peptidomimetics for Inhibition of HER2:HER3 Heterodimerization in HER2-Positive Breast CancerShanthi Kanthala, Sashikanth Banappagari, Ameya Gokhale, et al.
Oncotarget|November 2, 2017
A peptidomimetic with a chiral switch is an inhibitor of epidermal growth factor receptor heterodimerizationShanthi P Kanthala, Yong-Yu Liu, Sitanshu Singh, et al.
International Journal of Oncology|May 28, 2011
Glucosylceramide synthase, a factor in modulating drug resistance, is overexpressed in metastatic breast carcinomaYong-Yu Liu, Gauri A Patwardhan, Ping Xie, et al.
Current Protocols|October 26, 2022
Assessment of Antitumor and Antiproliferative Efficacy and Detection of Protein-Protein Interactions in Cancer Cells from 3D Tumor SpheroidsJafrin Jobayer Sonju, Achyut Dahal, Vivitri Dewi Prasasty, et al.
Pageof 7

Showing results (11-20 of 66) with videos related to

Sort By:
Pageof 7
Bio-Protocol|April 27, 2026
Quantitative Analysis of Splenic Natural Killer Cells of Mice Using Imaging Flow CytometryMohammad N Amin, Md Saqline Mostaq, Mohammad B Uddin, et al.
World Journal of Gastroenterology|December 31, 2014
Effect of bilateral supraclavicular postoperative radiotherapy in middle and lower thoracic esophageal carcinomaYi Ren, Chang Su, Yang Zhou, et al.
International Journal of Molecular Sciences|June 13, 2025
Glucosylceramide Synthase, a Key Enzyme in Sphingolipid Metabolism, Regulates Expression of Genes Accounting for Cancer Drug ResistanceMd Saqline Mostaq, Lin Kang, Gauri A Patwardhan, et al.
Journal of Thoracic Disease|January 16, 2015
Thoracoscopic left upper lobectomy with systematic lymph nodes dissection under left pulmonary artery clampingYi-Nan Dong, Nan Sun, Yi Ren, et al.
Apoptosis : an International Journal on Programmed Cell Death|November 26, 2010
Mutant p53 exhibits trivial effects on mitochondrial functions which can be reactivated by ellipticine in lymphoma cellsFei Wang, Jianfeng Liu, Delira Robbins, et al.
Cancer Research|February 1, 2011
Suppression of glucosylceramide synthase restores p53-dependent apoptosis in mutant p53 cancer cellsYong-Yu Liu, Gauri A Patwardhan, Kaustubh Bhinge, et al.
Chemical Biology & Drug Design|October 28, 2014
Novel Peptidomimetics for Inhibition of HER2:HER3 Heterodimerization in HER2-Positive Breast CancerShanthi Kanthala, Sashikanth Banappagari, Ameya Gokhale, et al.
Oncotarget|November 2, 2017
A peptidomimetic with a chiral switch is an inhibitor of epidermal growth factor receptor heterodimerizationShanthi P Kanthala, Yong-Yu Liu, Sitanshu Singh, et al.
International Journal of Oncology|May 28, 2011
Glucosylceramide synthase, a factor in modulating drug resistance, is overexpressed in metastatic breast carcinomaYong-Yu Liu, Gauri A Patwardhan, Ping Xie, et al.
Current Protocols|October 26, 2022
Assessment of Antitumor and Antiproliferative Efficacy and Detection of Protein-Protein Interactions in Cancer Cells from 3D Tumor SpheroidsJafrin Jobayer Sonju, Achyut Dahal, Vivitri Dewi Prasasty, et al.
Pageof 7